Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
8.90
+0.14 (1.60%)
At close: Dec 5, 2025, 4:00 PM EST
9.43
+0.53 (5.96%)
After-hours: Dec 5, 2025, 7:59 PM EST
Fulcrum Therapeutics Employees
Fulcrum Therapeutics had 45 employees as of December 31, 2024. The number of employees decreased by 31 or -40.79% compared to the previous year.
Employees
45
Change (1Y)
-31
Growth (1Y)
-40.79%
Revenue / Employee
n/a
Profits / Employee
-$1,580,311
Market Cap
481.65M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
FULC News
- 15 hours ago - Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 days ago - Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease on December 7, 2025 - GlobeNewsWire
- 4 weeks ago - Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting - GlobeNewsWire
- 5 weeks ago - Fulcrum Therapeutics, Inc. (FULC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025 - GlobeNewsWire
- 6 weeks ago - Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET - GlobeNewsWire
- 3 months ago - Fulcrum Therapeutics to Present at Upcoming Investor Meetings - GlobeNewsWire
- 4 months ago - Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025 - GlobeNewsWire